The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: A data update from the iMATRIX alectinib phase I/II open-label, multi-center study.
 
Francois Doz
Consulting or Advisory Role - Ipsen (Inst); Novartis (Inst); SERVIER (Inst)
Research Funding - ONXEO (Inst); SYNTH-INNOVE (Inst)
 
Michela Casanova
Consulting or Advisory Role - Alexion Pharmaceuticals (Inst); AstraZeneca; Bayer; Roche/Genentech; Servier
 
Kyung-Nam Koh
No Relationships to Disclose
 
Karsten Nysom
Consulting or Advisory Role - Bayer Health; EUSA Pharma; Lilly; Y-mAbs Therapeutics
 
Adela Canete
No Relationships to Disclose
 
Hyoung Jin Kang
No Relationships to Disclose
 
Matthias Karajannis
Consulting or Advisory Role - Cardinal Health; CereXis; Medscape; Physicans' Education Resource; QED Therapeutics; Recursion Pharmaceuticals
 
Darren Hargrave
Honoraria - Alexion Pharmaceuticals; AstraZeneca/MedImmune; Bayer
Consulting or Advisory Role - AstraZeneca; Bayer; Biodexa; Boehringer Ingelheim; Day One Biopharmaceuticals; Ipsen; Novartis; Roche/Genentech
Speakers' Bureau - Alexion Pharmaceuticals
Research Funding - AstraZeneca
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Boehringer Ingelheim; Novartis; Roche/Genentech
Other Relationship - Abbvie; AstraZeneca/MedImmune; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Day One Therapeutics; Epizyme; Novartis
 
Nadege Corradini
No Relationships to Disclose
 
Yeming Wu
No Relationships to Disclose
 
Huanmin Wang
No Relationships to Disclose
 
David Ziegler
Consulting or Advisory Role - Accendatech; Alexion Pharmaceuticals; Amgen; AstraZeneca/Merck; Bayer; Day One Biopharmaceuticals; FivePhusion; Norgine; Novartis
Research Funding - Accendatech (Inst)
Travel, Accommodations, Expenses - Bayer
 
Nicolas Prud'homme
No Relationships to Disclose
 
Carla Manzitti
No Relationships to Disclose
 
Quentin Campbell-Hewson
No Relationships to Disclose
 
Carolina Sturm
Employment - F. Hoffmann LaRoche; Genentech
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Tao Xu
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Dhruvitkumar Sutaria
Employment - Genentech
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Francis Mussai
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Amar Gajjar
Consulting or Advisory Role - Day One Therapeutics; Gennao Bio; QED Therapeutics; Roche/Genentech
Research Funding - Genentech (Inst); Kazia Therapeutics (Inst)